Bharat Biotech’s iNCOVACC, the first intranasal Covid-19 vaccine approved for mix-and match booster inoculation, is priced at Rs 800 per dose for private market and at Rs 325 for large-volume government procurement.
The vaccine is available on the government's CoWIN website and it will be in the market by the fourth week of January, said the Hyderabad-based company.
Health Ministry sources said that no decision has been taken on whether to procure the nasal vaccine for the national Covid-19 vaccination drive.
iNCOVACC (BBV154) was approved by the Central Drugs Standard Control Organization (CDSCO) earlier this month for use as a